On November 29, 2018, the Health Resources and Services Administration (HRSA) confirmed the effective date of its final rule on the 340B Drug Pricing Program. The rule institutes new ceiling prices on 340B drugs and authorizes monetary penalties against drug manufacturers that intentionally charge covered entities above the ceiling price. After multiple delays, the rule will go into effect on January 1, 2019.
